The HCPLive conference coverage page features articles, videos, and expert-led live coverage from major medical meetings throughout the year.
AAN 2011: Laquinimod Reduces Relapses in Multiple Sclerosis
Study results show that oral laquinimod reduces the annual relapse rate in patients with relapsing-remitting multiple sclerosis.
AACE 2011: Survey Reveals More Than Half of Diabetes Patients Experience Low Blood Sugar
More than half of patients with type 2 diabetes have experienced hypoglycemia, with many reporting experiences during activities such as driving and working.
AACE 2011: New Agents for the Treatment of Diabetes
Research shows promising results for PPAR modulators, long-acting GLP-1 receptor agonists, SGLT2 inhibitors, and other new classes of diabetes treatments.
AACE 2011: Endocrinology, Critical Illness, and Clinical Trials: Perils and Pitfalls
Poorly designed trials evaluating hormonal control in critically ill patients may lead to erroneous conclusions with serious consequences for patients.
AACE 2011: Personalizing Cancer Therapy Based on Molecular Markers and Models
Molecular medicine is the future of cancer treatment, but also has many potential applications in endocrinology.
AAN 2011: Qutenza Patch Reduces Postherpetic Neuralgia Pain in Multiple Subgroups of Patients
Patients treated with Qutenza reported significant relief from pain associated with PHN, regardless of gender, age, PHN duration, or baseline pain score.
AAN 2011: Novel Selegiline Delivery Can Inhibit Brain MAO-A with Lower Tyramine Risk -- Implications for Parkinson's Disease
Selegiline inhibits MAO-A in the brain of patients with Parkinson's Disease without elevating the risk of hypertensive crisis from dietary tyramine.
AAN 2011: Oral Cladribine Reduces Relapses in MS Patients Who Failed Injectable Therapies
Results from the CLARITY study show cladribine reduces the relapse rate in multiple sclerosis patients who have failed other disease-modifying therapies.
AAN 2011: Amantadine Improves Consciousness in TBI Patients with Disorders of Consciousness
Amantadine promotes rapid functional recovery in patients with disorders of consciousness after traumatic brain injury.
AAN 2011: Cost/Benefit Ratio Favors Transdermal Rivastigmine in Alzheimer's Disease
Study shows that rivastigmine provides an equal or larger number of quality-adjusted life-years at a lower cost than other treatments.
AAN 2011: Late Administration of Inhaled Dihydroergotamine Still Reduces Migraine Pain
Patients treated with Levadex, an orally inhaled dihydroergotamine, experienced significant migraine pain relief, even when treated hours after symptom onset.
AAN 2011: Ataluren Reduces Decline in Ambulation in Duchenne Muscular Dystrophy
Study results presented at AAN 2011 show that an experimental oral drug reduces the loss in ambulatory function in boys with Duchenne muscular dystrophy.
AAN 2011: Tool Predicts Disability Timeline for Progressive MS
Mayo Clinic researchers can predict whether patients will suffer a faster onset of disability and counsel them to help ease anxiety.
2011 AAN: Lea Thompson Hosts New, Free Video for Alzheimer's Patients
Film and television actress Lea Thompson is the host of the American Academy of Neurology Foundation's latest patient education video and guidebook.
2011 AAN: Oral Drug for MS Significantly Reduces Disease Activity and Slows Disability
The drug laquinimod reduced the number of relapses for people with multiple sclerosis (MS), in a large, long-term Phase III clinical study.
2011 AAN: AAN Issues New Guideline on Best Treatments for Diabetic Nerve Pain
The American Academy of Neurology has issued a new guideline on the most effective treatments for diabetic nerve pain.
2011 AAN Pre-conference Coverage: Non-Alzheimer's Dementia
When a dementia diagnosis isn't Alzheimer's diease, the neurologist's job becomes much trickier.
2011 AAN Pre-conference Coverage: Neurodegeneration with Brain Iron Accumulation
When a neurologist encounters a patient with a form of NBIA, it's often their first patient with NBIA.
HCPLive Conference Information: AACE 2011
Scheduling, session topics, satellite symposia, and other information for physicians planning to attend AACE 2011.
2011 AAN Pre-conference Coverage: Frontotemporal Dementia
Dr. Bruce Miller previews what he will be discussing about frontotemporal dementia at the upcoming American Academy of Neurology Annual Meeting.
2011 AAN Pre-conference Coverage: Biomarkers for Diagnosing Alzheimer's
Dr. Jeffrey Burns previews what he will be discussing about Alzheimer's disease at the upcoming American Academy of Neurology Annual Meeting.
HCPLive Conference Information: AAN 2011
Scheduling, session topics, keynote speakers, and other information for physicians planning to attend AAN 2011.
2011 ACC: Shorter Duration of Antiplatelet Therapy for Select Patients
How long should a patient take an antiplatelet drug to reduce clotting following a stent procedure?
Hospital to Home (H2H) Learning Destination at ACC11
The H2H initiative includes the use of innovative health technologies such as HIT solutions, home monitoring devices, and telehealth resources.
2011 ACC: EHRs Are Making an Impact
EHRs address a key barrier to care as cardiologists lack the information and the tools to apply their knowledge to all of their patients all of the time.
2011 ACC: Implantable Pacemaker-like Device Can Keep Blood Pressure in Check
Study results show Rheos implantable device is effective at lowering blood pressure in patients with drug-resistant hypertension.
2011 ACC: Radial Access Coronary Intervention Gets High Marks in Multicenter Study
RIVAL study shows radial access for coronary interventions reduces vascular complications.
2011 ACC: ARBs and CCB Both Work to Control Adverse Events in Hypertension
No significant differences on cardiovascular outcomes were seen in a trial that compared ARBs to CCBs in patients with glucose tolerance and hypertension.
2011 ACC: OSCAR Study Shows Combo Therapy Better Than Monotherapy for Hypertensives
Combination calcium channel blocker and angiotensin II receptor blocker proves most effective in a study of elderly patients with hypertension.
2011 ACC VIDEO: Dr. Joe Kim Talks with Dr. Ethan Anderson
Dr. Joe Kim speaks with Dr. Ethan Anderson about what's being discussed at ACC's 60th Annual Scientific Sessions.